APPENDIX 12
Individual Hematological Findings,

Subject

No.

Plat.

_(x10-3)

WBC

—(xl0-3)

Neut,

—cx0-3)

Lymph.

—xto-3)

Mono,

——(K10-3)

Eosin.

—cxtom3)

1966

Baso.

Het.

39
37
39

—cxton4)

Heb.

9)

Rongelap Exposed Males 12-15
2
3
5
19
32
54
83%
85*
Mean

12.84
5.79
6.61
8.95
6.57
3.70
8.19
9.57

7.44
2.49
2.97
4.83
2.63
1.00
4.75
4.98

3.85
2.08
2.97
2.86
2.83
1,73
2.78
3.82

0.51
0.12
0.13
0.27
0.07
0.07
0.25
0.48

1.03
0.93
0.53
0.98
0.92
0.85
0.33
0.29

0.0
1.70
0.0
0.90
1.30
0.40
0,80
0.0

7.77
+2. 16%

3,88
1.9

2.86
0.8

0.24

0.73

0.64

38.8
2.2

4]
40
38
38

Ailingnae Exposed Males 12-15
ir

~

6

84%

7.58

3.87
1.31

2.97

0.10

0.38

0.76

0.0

40

6.22

2.59

2.78

0.24

0.60

0.25

38.5

4.87

2.58

0.44

0.50

37

Rongelap Exposed Females 12-15
17
21
33
42
65
86*

5.78
5.74
5.37
6.69
7.40
9.81

2.20
2.58
2.95
3.81
5.03
3,63

2.49
2.41
1.66
1.94
1.70
3,24

0.17
0.17
0.11
0.0
0.37
0.0

0.92
0.46
0.64
0.80
0.22
2.84

0.0
1,10
0.0
1.30
0.70
1.00

33
37
42
38
39
40

6.79
+1.5

3,36
0.9

2,24
0.5

0.14

0.98

0.68

38.1
3.5

1.30

36

Ailingnae Exposed Females 12-15
8

12.45

*Exposed in utero.
*«*kStandard deviation.

9.71

2.24

0,37

0.0

13.0

13.0

Serum
Protein

2)

Select target paragraph3